Cargando…

Is the ecarin clotting time (ECT) a valid monitoring parameter for r-hirudin-based anticoagulation in continuous renal replacement therapy?

Detalles Bibliográficos
Autores principales:	v Heymann, C, Vargas Hein, O, Ziemer, S, Sinha, P, Schröder, T, Nissen, J, Lips, M, Spies, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332960/ http://dx.doi.org/10.1186/cc756

Ejemplares similares

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting Assay: A Prospective, Single-Arm, Open-Label Study
por: Fong, Alan Yean Yip, et al.
Publicado: (2020)

Expression and Characterization of Recombinant Ecarin
por: Jonebring, Anna, et al.
Publicado: (2012)

Hirudin as an anticoagulant for both haematology and chemistry tests
por: Kumura, Takeo, et al.
Publicado: (2000)

Self-regulated hirudin delivery for anticoagulant therapy
por: Xu, Xiao, et al.
Publicado: (2020)

Potential Application of Recombinant Snake Prothrombin Activator Ecarin in Blood Diagnostics
por: Zhao, Kong-Nan, et al.
Publicado: (2022)

Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients
por: Moore, Gary W
Publicado: (2007)

Endotoxin-induced capillary perfusion failure and leukocyte adhesion is not prevented by the thrombin inhibitor hirudin: an intravital microscopic study
por: Hoffmann, JN, et al.
Publicado: (2000)

Safety of ECT in patients receiving an oral anticoagulant
por: Centanni, Nicolette R., et al.
Publicado: (2021)

The hirudin-like factors HLF3 and HLF4—hidden hirudins of European medicinal leeches
por: Müller, Christian, et al.
Publicado: (2020)

A novel stearic acid-modified hirudin peptidomimetic with improved pharmacokinetic properties and anticoagulant activity
por: Liu, Zhuguo, et al.
Publicado: (2015)

Filter clotting with continuous renal replacement therapy in COVID-19
por: Endres, Paul, et al.
Publicado: (2020)

Filter Clotting with Continuous Renal Replacement Therapy in COVID-19
por: Rosovsky, Rachel P., et al.
Publicado: (2020)

A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood
por: van der Maten, Erika, et al.
Publicado: (2017)

Cloning, Expression and Purification of Full-length Recombinant Ecarin and Comparing Its Expression and Function with Its Truncated Form
por: Jafari, Zohreh, et al.
Publicado: (2022)

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
por: Sun, Yuelin, et al.
Publicado: (2023)

STUDIES IN EXPERIMENTAL EXTRACORPOREAL THROMBOSIS : III. EFFECTS OF CERTAIN ANTICOAGULANTS (HEPARIN AND HIRUDIN) ON EXTRACORPOREAL THROMBOSIS AND ON THE MECHANISM OF THROMBUS FORMATION.
por: Shionoya, Takuji
Publicado: (1927)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Simplified method of regional citrate anticoagulation for continuous extra renal epuration
por: Cointault, O, et al.
Publicado: (2002)

Use of activated clotting time to monitor anticoagulation in patients receiving unfractionated heparin on renal replacement therapy
por: Bidwai, A, et al.
Publicado: (2011)

Repetitive enhancement of serum BDNF subsequent to continuation ECT
por: Vanicek, T., et al.
Publicado: (2019)

Continuous hemodiafiltration with bicarbonate- and lactate-buffered replacement fluids in septic shock
por: Lewejohann, J-C, et al.
Publicado: (1999)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Troponin T as myocardial ischemia marker to guide therapy with positive inotropes in septic shock patients
por: Hein, OV, et al.
Publicado: (1997)

The effect of recombinant hirudin on rabbit ear flaps with venous insufficiency
por: Duzgun, Serdar, et al.
Publicado: (2014)

Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review
por: Junren, Chen, et al.
Publicado: (2021)

Report on the First International Congress on Systemic Medicine, Gas Discharge Visualization (GDV) and Electro-oncotherapy (ECT)
por: Olalde Rangel, José A., et al.
Publicado: (2005)

Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT
por: Viswanath, Biju, et al.
Publicado: (2011)

Does ECT Work? the Impact of ECT on Depression
por: Collins, Dawn
Publicado: (2023)

Dosing patterns for continuous renal replacement therapy in the United States
por: Venkataraman, R, et al.
Publicado: (2001)

Long-term alcoholic patients have decreased perioperative cAMP levels
por: Schoenfeld, H, et al.
Publicado: (2006)

THE PRACTICE OF ECT IN INDIA: II. THE PRACTICAL ADMINISTRATION OF ECT
por: Andrade, Chittaranjan, et al.
Publicado: (1993)

Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response
por: Deng, Fei, et al.
Publicado: (2019)

Hirudin inhibits glioma growth through mTOR‐regulated autophagy
por: Ma, Ying, et al.
Publicado: (2023)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Influence of enoximone and dobutamine upon liver perfusion and function in fluid optimized septic patients
por: Kern, H, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_2f77blpa4n86tsk3brlnlfbe3j